Elevance Health Inc (ELV)

NYSE
Currency in USD
379.21
+4.92(+1.31%)
Real-time Data·
ELV Scorecard
Full Analysis
Management has been aggressively buying back shares
Trading near 52-week Low
Fair Value
Day's Range
357.67379.33
52 wk Range
357.67567.26
Key Statistics
Edit
Prev. Close
374.29
Open
368
Day's Range
357.67-379.33
52 wk Range
357.67-567.26
Volume
1.51M
Average Vol. (3m)
1.72M
1-Year Change
-29.99%
Book Value / Share
187.74
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ELV Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
505.44
Upside
+33.29%
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 14 consecutive years
Show more

Elevance Health Inc Company Profile

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. It operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. The company offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. It also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, the company provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. It provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.

Elevance Health Inc SWOT Analysis


Analyst Perspectives
Discover diverse analyst views on Elevance Health, with price targets ranging from $478 to $622, reflecting varied assessments of the company's prospects
Diversified Performance
Learn how Elevance Health's varied business segments, including strong commercial and Medicare operations, contribute to its overall financial stability
Strategic Acquisitions
Delve into Elevance Health's expansion in the specialty pharmacy sector through key acquisitions, positioning the company for potential future growth
Medicaid Headwinds
Explore Elevance Health's challenges in its Medicaid business, including increased utilization and rate mismatches, impacting EPS guidance and growth expectations
Read full SWOT analysis

Elevance Health Inc Earnings Call Summary for Q1/2025

  • Q1 2025 adjusted EPS of $11.97, up 10% YoY, beating $11.08 forecast; revenue reached $48.8B, up 15% YoY
  • Stock rose 1.25% pre-market; company reaffirmed 2025 adjusted EPS guidance of $34.15-$34.85
  • Carillon segment showed strong 34% growth; Health Benefits operating gain at $2.2B
  • CEO emphasized strategic focus on simplifying healthcare experience and enhancing patient care
  • Risks include elevated healthcare costs, regulatory changes, and competitive pressures in the sector
Last Updated: 04/22/2025, 09:35 AM
Read Full Transcript

Compare ELV to Peers and Sector

Metrics to compare
ELV
Peers
Sector
Relationship
P/E Ratio
14.4x10.1x−0.5x
PEG Ratio
−4.490.070.00
Price / Book
2.0x1.7x2.6x
Price / LTM Sales
0.5x1.0x2.9x
Upside (Analyst Target)
33.7%28.0%51.4%
Fair Value Upside
Unlock−0.9%9.5%Unlock

Analyst Ratings

18 Buy
4 Hold
0 Sell
Ratings:
22 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 505.44
(+33.29% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 25.71%
Dividend Yield
1.82%
Industry Median 1.54%
Annualized Payout
6.84
Paid quarterly
5-Years Growth
+14.52%
Growth Streak

Earnings

Latest Release
Apr 22, 2025
EPS / Forecast
11.97 / 11.08
Revenue / Forecast
48.80B / 46.27B
EPS Revisions
Last 90 days

People Also Watch

283.49
COR
+1.55%
264.09
UNH
-14.26%
66.04
NVO
+2.52%
732.37
LLY
+2.35%

FAQ

What Is the Elevance Health (ELV) Stock Price Today?

The Elevance Health stock price today is 379.21

What Stock Exchange Does Elevance Health Trade On?

Elevance Health is listed and trades on the New York Stock Exchange stock exchange.

What Is the Stock Symbol for Elevance Health?

The stock symbol for Elevance Health is "ELV."

Does Elevance Health Pay Dividends? What’s The Current Dividend Yield?

The Elevance Health dividend yield is 1.83%.

What Is the Elevance Health Market Cap?

As of today, Elevance Health market cap is 85.26B.

What Is Elevance Health's Earnings Per Share (TTM)?

The Elevance Health EPS (TTM) is 25.71.

When Is the Next Elevance Health Earnings Date?

Elevance Health will release its next earnings report on Jul 16, 2025.

From a Technical Analysis Perspective, Is ELV a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.